TORONTO, ONTARIO -- (Marketwired) -- 08/14/15 -- Cynapsus Therapeutics Inc. (NASDAQ: CYNA)(TSX: CTH) ("Cynapsus" or the "Company"), a specialty Central Nervous System ("CNS") pharmaceutical company developing and preparing to commercialize a fast-acting, easy-to-use, ...
↧